Plus, news about Neumora, Erasca, FibroGen, Tilt Biotherapeutics, Sangamo, Leap Therapeutics, Remedy Plan, Lexeo, Karyopharm, Tango Therapeutics and Humacyte:
Axsome Therapeutics gets Blackstone’s help: The commercial-stage CNS drugmaker signed a
↧